Lieberman A - Search Results

1

Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementia.

Hubble JP, Kurth JH, Glatt SL, Kurth MC, Schellenberg GD, Hassanein RE, Lieberman A, Koller WC. Hubble JP, et al. Among authors: lieberman a. Neuroepidemiology. 1998;17(2):96-104. doi: 10.1159/000026159. Neuroepidemiology. 1998. PMID: 9592786

2

Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease.

Simon DK, Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Nichols WC, Foroud T; Parkinson Study Group-PROGENI Investigators. Simon DK, et al. BMC Med Genet. 2010 Apr 1;11:53. doi: 10.1186/1471-2350-11-53. BMC Med Genet. 2010. PMID: 20356410 Free PMC article.

3

An algorithm for the management of Parkinson's disease.

Koller WC, Silver DE, Lieberman A. Koller WC, et al. Among authors: lieberman a. Neurology. 1994 Dec;44(12 Suppl 10):S1-52. Neurology. 1994. PMID: 7854513 Review. No abstract available.

4

Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease.

Hutton JT, Koller WC, Ahlskog JE, Pahwa R, Hurtig HI, Stern MB, Hiner BC, Lieberman A, Pfeiffer RF, Rodnitzky RL, Waters CH, Muenter MD, Adler CH, Morris JL. Hutton JT, et al. Among authors: lieberman a. Neurology. 1996 Apr;46(4):1062-5. doi: 10.1212/wnl.46.4.1062. Neurology. 1996. PMID: 8780092 Clinical Trial.

5

Family history of dementia: dementia with lewy bodies and dementia in Parkinson's disease.

Papapetropoulos S, Lieberman A, Gonzalez J, Singer C, Laufer DZ, Mash DC. Papapetropoulos S, et al. Among authors: lieberman a. J Neuropsychiatry Clin Neurosci. 2006 Winter;18(1):113-6. doi: 10.1176/jnp.18.1.113. J Neuropsychiatry Clin Neurosci. 2006. PMID: 16525079

6

Treatment of Parkinson's disease.

Lieberman AN. Lieberman AN. Mayo Clin Proc. 1988 Oct;63(10):1046-9. doi: 10.1016/s0025-6196(12)64923-4. Mayo Clin Proc. 1988. PMID: 3172854 Free article. No abstract available.

7

Statins, cholesterol, Co-enzyme Q10, and Parkinson's disease.

Lieberman A, Lyons K, Levine J, Myerburg R. Lieberman A, et al. Parkinsonism Relat Disord. 2005 Mar;11(2):81-4. doi: 10.1016/j.parkreldis.2004.07.012. Parkinsonism Relat Disord. 2005. PMID: 15734664

8

Dementia in Parkinson Disease.

Lieberman A, Dziatolowski M, Kupersmith M, Serby M, Goodgold A, Korein J, Goldstein M. Lieberman A, et al. Ann Neurol. 1979 Oct;6(4):355-9. doi: 10.1002/ana.410060409. Ann Neurol. 1979. PMID: 554525

9

Adrenal medullary transplants as a treatment for advanced Parkinson's disease.

Lieberman A, Ransohoff J, Berczeller P, Goldstein M. Lieberman A, et al. Prog Brain Res. 1990;82:665-9. doi: 10.1016/s0079-6123(08)62657-6. Prog Brain Res. 1990. PMID: 2290968 No abstract available.

10

MK 458, a selective and potent D2 receptor agonist in advanced Parkinson's disease.

Lieberman A, Chin L, Baumann G. Lieberman A, et al. Clin Neuropharmacol. 1988 Jun;11(3):191-200. doi: 10.1097/00002826-198806000-00001. Clin Neuropharmacol. 1988. PMID: 2900065

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

842 results

Search Page